Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Tax Provisions (2023 - 2025)

Immunocore Holdings' Tax Provisions history spans 3 years, with the latest figure at $14.2 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 1402.2% year-over-year to $14.2 million; the TTM value through Dec 2025 reached $16.4 million, up 987.24%, while the annual FY2025 figure was $16.4 million, 987.24% up from the prior year.
  • Tax Provisions for Q4 2025 was $14.2 million at Immunocore Holdings, up from $481000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $14.2 million in Q4 2025 and bottomed at -$5.9 million in Q4 2023.
  • The 3-year median for Tax Provisions is $328500.0 (2023), against an average of $746750.0.
  • The largest annual shift saw Tax Provisions crashed 1377.27% in 2024 before it skyrocketed 1402.2% in 2025.
  • A 3-year view of Tax Provisions shows it stood at -$5.9 million in 2023, then surged by 81.51% to -$1.1 million in 2024, then surged by 1402.2% to $14.2 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Tax Provisions are $14.2 million (Q4 2025), $481000.0 (Q3 2025), and $639000.0 (Q2 2025).